BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentDementia
Interventions
DIAGNOSTIC_TEST

Flutemetamol F18 Injection

PET imaging of Abeta amyloid

DIAGNOSTIC_TEST

[18F]-RO6958948 Injection

PET imaging of Tau aggregates

DIAGNOSTIC_TEST

[18F]-MK-6240 Injection

PET imaging of Tau aggregates

Trial Locations (1)

02906

Butler Hospital Memory and Aging Program, Providence

Sponsors
All Listed Sponsors
collaborator

The Warren Alpert Foundation

UNKNOWN

collaborator

Brown University

OTHER

collaborator

University of Rhode Island

OTHER

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

GE Healthcare

INDUSTRY

lead

Butler Hospital

OTHER